Molecular Identity
SUMATRIPTAN SUCCINATE
butanedioic acid;1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide
PubChem CID: 59772
Sumatriptan succinate is a succinate salt obtained by reaction of sumatriptan with one equivalent of succinic acid. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used for the acute treatment of migraine with or without aura in adults. It has a role as a serotonergic agonist and a vasoconstrictor agent. It contains a sumatriptan(1+).
2D Structure
Properties
C18H27N3O6S
Molecular Formula
413.50
Molecular Weight
g/mol
413.1621
Exact Mass
Da
148
TPSA
May have limited oral absorption
4
H-Bond Donors
8
H-Bond Acceptors
498
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
SUMATRIPTAN SUCCINATE103628-48-4Sumavel DoseProAlsumaOnzetra XsailImitrex StatdoseGR 43175CZembrace SymTouchSumatriptan GalpharmSumatriptan (as succinate)GR-43175CNSC-760362J8BDZ68989CHEBI:64359DTXSID60145966
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to SUMATRIPTAN SUCCINATE
Loading drug network...